Suramin, a novel antitumor compound
- 1 December 1990
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 37 (6) , 893-898
- https://doi.org/10.1016/0960-0760(90)90439-r
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Suramin in Adrenal Cancer: Modulation of Steroid Hormone Production, Cytotoxicityin Vitro, and Clinical Antitumor Effect*Journal of Clinical Endocrinology & Metabolism, 1990
- Recent developments in the cell biology of basic fibroblast growth factor.The Journal of cell biology, 1989
- Effects of Suramin on the Function and Structure of the Adrenal Cortex in the Cynomolgus MonkeyJournal of Clinical Endocrinology & Metabolism, 1987
- Clinical Pharmacokinetics of Suramin in Patients With HTLV‐III/LAV InfectionThe Journal of Clinical Pharmacology, 1986
- EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVOThe Lancet, 1985
- Suramin Protection of T Cells in Vitro Against Infectivity and Cytopathic Effect of HTLV-IIIScience, 1984
- Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virusNature, 1983
- Suramin: A potent inhibitor of the reverse transcriptase of RNA tumor virusesCancer Letters, 1979
- Suramin: With Special Reference to OnchocerciasisPublished by Elsevier ,1978
- SIGNIFICANCE OF THE INCREASED FREQUENCY OF SELECTIVE CORTICAL NECROSIS OF ADRENALJAMA, 1937